CRVS
Corvus Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Richard A. Miller
IPO Date
2016-03-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Corvus Pharmaceuticals, Inc.
CEO
Richard A. Miller
IPO Date
2016-03-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 15,000 |
| $11.60 |
| 15 Jun 2026 | CLARK IAN T | director | A-Award | Acquired | 15,000 | $11.60 |
| 15 Jun 2026 | Grais Linda | director | A-Award | Acquired | 15,000 | $11.60 |
| 15 Jun 2026 | Thompson Peter A. | director, 10 percent owner: | A-Award | Acquired | 15,000 | $11.60 |
| 15 Jun 2026 | van den Broek Richard | director | A-Award | Acquired | 15,000 | $11.60 |
| 20 May 2026 | MILLER RICHARD A MD | director, officer: President and CEO | P-Purchase | Acquired | 5,000 | $12.05 |
| 20 May 2026 | MILLER RICHARD A MD | director, officer: President and CEO | P-Purchase | Acquired | 1,932 | $12.01 |
| 27 Apr 2026 | Chan Andrew C. | director | A-Award | Acquired | 30,000 | $16.02 |
| 27 Apr 2026 | Chan Andrew C. | — | Disposed | 0 | $0.00 |